论文部分内容阅读
对11例流行性出血热(简称出血热)早期重症患者(经间接免疫荧光检测出血热特异性抗体阳性)用免疫血清治疗(从病程15—25天的出血热恢复期患者分离而来),免疫血清10ml 肌肉注射。并用11例入院病日及病情相似的出血热早期患者作对照。两组其他治疗相同。治疗结果:治疗组11例患者中1天内退热者10例(90%),平均退热时间为15.6小时。面对照组于1天内退热者仅5例(45%),平均退热时间49小时。两组有显著差异(P<0.05)。尿蛋白平均消失时间治疗组为4.5天,而对照组为11天(P<0.01)。发热期入院患
Eleven patients with early-stage severe disease (hemorrhagic fever-specific antibody detected by indirect immunofluorescence) were treated with immune serum (from patients with hemorrhagic fever convalescence of 15-25 days duration) in 11 early-stage severe hemorrhagic fever (HF) Immune serum 10ml intramuscular injection. 11 patients with early onset of hemorrhagic fever with similar onset of illness and similar conditions were used as controls. The other two groups of the same treatment. Treatment outcome: In the 11 patients in the treatment group, 10 patients (90%) had fever within one day, and the average antipyretic time was 15.6 hours. In the control group, only 5 patients (45%) had fever in one day and the average antipyretic time was 49 hours. There was significant difference between the two groups (P <0.05). Urine protein disappeared in the treatment group 4.5 days, while the control group was 11 days (P <0.01). Fever during admission